Home
Pyxis Oncology, Inc.

Pyxis Oncology, Inc. Market Share Analysis for June 2026

Charting a course to therapeutics for difficult-to-treat cancers.

Health > Biotechnology and Pharmaceuticals

Domainpyxisoncology.com

Year Founded2019

Employees51 - 200

Annual Revenue$5M - $10M

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. (including company regionals)

pyxisoncology.com

See more website traffic and engagement information

Pyxis Oncology, Inc. Revenue up to June 2026 is 5M - 10M

revenue generated by Pyxis Oncology, Inc. top domains

Pyxis Oncology, Inc. top domains revenue over 3 years

Revenue for Pyxis Oncology, Inc. top domains

pyxisoncology.com5M - 10M

See more with Sales Intelligence

Total visits to Pyxis Oncology, Inc.'s top domains

Understand Pyxis Oncology, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pyxisoncology.com6K

See more with Sales Intelligence

Avg. visit duration in Pyxis Oncology, Inc.'s top domains

Analyze Pyxis Oncology, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pyxisoncology.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Pyxis Oncology, Inc.'s top domains

See how Pyxis Oncology, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pyxisoncology.com2.21

See more with Sales Intelligence

Pyxis Oncology, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Pyxis Oncology, Inc.

These are the website technologies, by industry, used by Pyxis Oncology, Inc. top domains

Payment & Currencies (5)

Cart Functionality

Widget (5)

Twemoji

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

More Technologies

9

See all

News & Signals from Pyxis Oncology, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPyxis Oncology, Inc. was planning to receive financing of $114M in Private Placement Financing on Jun 30th '26.Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

NewsPyxis Oncology, Inc. hired Nelson Azoulay as Chief Business Officer on May 7th '26.Pyxis Oncology (Nasdaq: PYXS) announced the appointment of Nelson Azoulay as Chief Business Officer on May 7, 2026.

NewsPyxis Oncology, Inc. hired Alex Kane as Senior Vice President, Investor Relations & Capital Markets on Oct 9th '25.BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) - Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced the appointment of Alex Kane, MBA, as Senior Vice President, Investor Relations & Capital Markets, effective immediately.